Evaluation of MET alteration in EGFR-mutant non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor from paired biopsy: A retrospective cohort study

作者
Bo Mi Ku,Sungwon Park,Sehhoon Park,Hyun Ae Jung,Jong‐Mu Sun,Se‐Hoon Lee,Jin Seok Ahn,Yoon‐La Choi,Myung‐Ju Ahn
出处
期刊:Precision and future medicine [Sungkyunkwan University School of Medicine]
卷期号:6 (4): 233-242 被引量:1
标识
DOI:10.23838/pfm.2022.00058
摘要

Purpose: Mesenchymal-epithelial transition tyrosine kinase receptor (MET) amplification is one of the common acquired resistance mechanisms to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). To evaluate the usefulness of screening methods for MET status, we studied the impact of MET amplification or protein overexpression in EGFR-mutant non-small cell lung cancer patients who were treated with EGFR TKI.Methods: A total of 214 patients treated with EGFR TKI as first-line therapy with available tissue biopsy was analyzed. Paired biopsies were obtained from 111 patients at baseline and at onset of resistance. MET status was determined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).Results: Among 111 patients with paired samples, incidence of MET alteration was increased according to both MET overexpression by IHC (14.4% to 22.5%) and MET amplification by FISH (1.8% to 8.1%) with moderated to strong IHC intensity samples after EGFR TKI treatment. In patients treated with 1st-generation EGFR TKI, MET amplification by FISH was significantly related to shorter progression-free survival (P=0.04) and overall survival (P=0.01). In contrast, there was no difference in clinical outcomes according to MET intensity of IHC. Patients harboring MET amplification by FISH were associated with poor clinical outcomes compared to those with T790M mutation at progression.Conclusion: These results suggest that FISH is more informative than IHC for identification of patients with MET amplification as an EGFR TKI resistance mechanism. Given the poor outcome in patients who developed MET amplification, combinational trials with more active MET inhibitor are needed to overcome resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
居糯糯完成签到,获得积分10
刚刚
沾沾完成签到,获得积分10
刚刚
1秒前
张宇发布了新的文献求助10
1秒前
梧wu完成签到,获得积分10
1秒前
王灿完成签到,获得积分10
1秒前
积极老四完成签到,获得积分10
1秒前
夹生饭完成签到,获得积分10
1秒前
顾矜的应助被古朵采纳,获得10
2秒前
桐桐的应助被痴情志浩采纳,获得10
2秒前
2秒前
2秒前
hao完成签到 ,获得积分20
3秒前
lsq108完成签到,获得积分10
3秒前
渡人舟的应助被anc采纳,获得10
3秒前
毛毛完成签到 ,获得积分10
3秒前
3秒前
蓝天的应助被phdyhm采纳,获得10
4秒前
vigrous发布了新的文献求助10
4秒前
NexusExplorer的应助被甜筒采纳,获得10
4秒前
笑点低愫完成签到,获得积分10
4秒前
4秒前
WWW完成签到,获得积分10
4秒前
丘比特的应助被qq采纳,获得10
5秒前
joy发布了新的文献求助10
5秒前
crush发布了新的文献求助10
6秒前
6秒前
伸手摘星_浩完成签到 ,获得积分10
6秒前
6秒前
6秒前
7秒前
smh发布了新的文献求助10
7秒前
Criminology34的应助被Huimin采纳,获得20
7秒前
Criminology34的应助被Huimin采纳,获得10
7秒前
JamesPei的应助被lingzi1015采纳,获得20
7秒前
TCcc发布了新的文献求助10
8秒前
无极微光的应助被Yy采纳,获得20
8秒前
lull完成签到 ,获得积分10
8秒前
8秒前
领导范儿的应助被武科大采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707